Georgia 2025-2026 Regular Session

Georgia House Bill HB473 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	25 LC 48 1480~~/AP~~
2		-	House Bill 473 ~~(AS PASSED HOUSE AND SENATE)~~
	1	+	25 LC 48 1480
	2	+	House Bill 473
3	3		By: Representatives Stephens of the 164
4	4		th
5	5		, Hawkins of the 27
6	6		th
7	7		, and Newton of the 127
8	8		th
9	9
10	10		A BILL TO BE ENTITLED
11	11		AN ACT
12	12		To amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to
13	13		1
14	14		controlled substances, so as to provide for certain provisions relating to Schedule I controlled2
15	15		substances; to provide for certain provisions relating to the definition of dangerous drugs; to3
16	16		provide for related matters; to provide for an effective date; to repeal conflicting laws; and4
17	17		for other purposes.5
18	18		BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:6
19	19		SECTION 1.7
20	20		Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled8
21	21		substances, is amended in Code Section 16-13-25, relating to Schedule I controlled9
22	22		substances, by revising subparagraph (TT) of paragraph (1) as follows:10
23	23		"(TT) Methyl
24	24		2-methyl-AP-237;"11
25	25		SECTION 2.12
26	26		Said chapter is further amended in Code Section 16-13-25, relating to Schedule I controlled13
27	27		substances, by revising subparagraph (CC) of paragraph (3) as follows:14
28	28		"(CC) Acetylpsilocin (4-acetoxy-N,N-dimethyltryptamine, 4-AcO-DMT); Reserved;"15
29	29		H. B. 473
30		-	- 1 - 25 LC 48 1480~~/AP~~
	30	+	- 1 - 25 LC 48 1480
31	31		SECTION 3.
32	32		16
33	33		Said chapter is further amended in Code Section 16-13-25, relating to Schedule I controlled17
34	34		substances, by adding a new subparagraph to paragraph (4) to read as follows:18
35	35		"(A.5) Ethylphenidate;
36	36		"19
37	37		SECTION 4.20
38	38		Said chapter is further amended in Code Section 16-13-25, relating to Schedule I controlled21
39	39		substances, by adding a new subdivision to division (13)(E)(ii) to read as follows:22
40	40		"(III) Tetrahydrothiophene group;"23
41	41		SECTION 5.24
42	42		Said chapter is further amended in Code Section 16-13-71, relating to dangerous drug, by25
43	43		adding new paragraphs to subsection (b) to read as follows:26
44	44		"(12.8) Acoramidis;"27
45	45		"(17.07) Afamitresgene autoleucel;"28
46	46		"(62.45) Aprocitentan;"29
47	47		"(63.3) Arimoclomol;"30
48	48		"(68.133) Atidarsagene autotemcel;"31
49	49		"(69.23) Axatilimab-csfr;"32
50	50		"(153.65) Ceftobiprole medocaril sodium;"33
51	51		"(206.6) Coagulation Factor IX (recombinant);"34
52	52		"(213.2) Concizumab-mtci;"35
53	53		"(216.5) Cosibelimab-ipdl;"36
54	54		"(217.3) Crinecerfont;"37
55	55		"(220.5) Crovalimab-akkz;"38
56	56		"(238.5) Danicopan;"39
57	57		"(256.58) Deuruxolitinib;"40
58	58		H. B. 473
59		-	- 2 - 25 LC 48 1480~~/AP~~
	59	+	- 2 - 25 LC 48 1480
60	60		"(256.8) Deutivacaftor;"41
61	61		"(316.45) Donanemab-azbt;"42
62	62		"(331.0504) Eladocagene exuparvovec-tneq;43
63	63		(331.0506) Elafibranor;"44
64	64		"(331.0515) Elaparvovec-dzkt;"45
65	65		"(332.3) Enmetazobactam;"46
66	66		"(332.73) Ensartinib;47
67	67		(332.75) Ensifentrine;"48
68	68		"(380.45) Exagamglogene autotemcel;"49
69	69		"(402.3) Flurpiridaz F 18;"50
70	70		"(415.005) Givinostat;"51
71	71		"(464.9) Imetelstat;"52
72	72		"(466.8) Immune globulin, Human;"53
73	73		"(469.02) Inavolisib;"54
74	74		"(487.09) Iomeprol;"55
75	75		"(512.1) Landiolol;"56
76	76		"(513.03) Lazertinib;57
77	77		(513.07) Lebrikizumab-lbkz;"58
78	78		"(513.79) LetibotulinumtoxinA-wlbg;"59
79	79		"(514.3) Levacetylleucine;"60
80	80		"(520.1) Lifileucel;"61
81	81		"(530.3) Lovotibeglogene autotemcel;"62
82	82		"(540.47) Marstacimab-hncq;"63
83	83		"(540.8) Mavorixafor;"64
84	84		"(638.9) Nemolizumab-ilto;"65
85	85		"(649) Nogapendekin alfa inbakicept-pmln;"66
86	86		"(661.02) Obecabtagene autoleucel;"67
87	87		H. B. 473
88		-	- 3 - 25 LC 48 1480~~/AP~~
	88	+	- 3 - 25 LC 48 1480
89	89		"(663.03) Olezarsen;"68
90	90		"(681.55) Palopegteriparatide;"69
91	91		"(692.5175) Pegulicianine;"70
92	92		"(835.7) Resmetirom;"71
93	93		"(836.75) Revumenib;"72
94	94		"(852.55) Seladelpar;"73
95	95		"(860.5) Smallpox and mpox (vaccinia) vaccine;"74
96	96		"(881.04) Sofpironium;"75
97	97		"(883.55) Sotatercept-csrk;"76
98	98		"(927.3) Sulopenem etzadroxil;"77
99	99		"(931.17) Tarlatamab-dlle;"78
100	100		"(967.625) Tislelizumab-jsgr;"79
101	101		"(973.55) Tovorafenib;"80
102	102		"(1021.65) Vadadustat;"81
103	103		"(1025.3) Vanzacaftor;"82
104	104		"(1037.4) Vorasidenib;"83
105	105		"(1039.05) Xanomeline;"84
106	106		"(1042.035) Zanidatamab-hrii;"85
107	107		"(1042.047) Zenocutuzumab-zbco;"86
108	108		"(1042.79) Zolbetuximab-clzb;"87
109	109		SECTION 6.88
110	110		Said chapter is further amended in Code Section 16-13-71, relating to dangerous drug, by89
111	111		adding a new subparagraph to paragraph (59) of subsection (b) to read as follows:90
112	112		"(ZZ.5) Peanut (arachis hypogaea) allergen powder-dnfp;"91
113	113		H. B. 473
114		-	- 4 - 25 LC 48 1480~~/AP~~
	114	+	- 4 - 25 LC 48 1480
115	115		SECTION 7.
116	116		92
117	117		This Act shall become effective upon its approval by the Governor or upon its becoming law93
118	118		without such approval.94
119	119		SECTION 8.95
120	120		All laws and parts of laws in conflict with this Act are repealed.96
121	121		H. B. 473
122	122		- 5 -